| William John Horan, MD | |
|
220 Nash Medical Arts Mall, Rocky Mount, NC 27804-1470 | |
| (252) 962-4550 | |
| (252) 962-4551 |
| Full Name | William John Horan |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 43 Years |
| Location | 220 Nash Medical Arts Mall, Rocky Mount, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801880687 | NPI | - | NPPES |
| 8944466 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 9400274 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Carolina Hospital | Sanford, NC | Hospital |
| Carolinas Healthcare System-blue Ridge | Morganton, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dlp Central Carolina Medical Group Llc | 3577840420 | 28 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
| Entity Name | Blue Ridge Regional Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447261698 PECOS PAC ID: 0648181966 Enrollment ID: O20040729001574 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
| Entity Name | Vidant Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477648731 PECOS PAC ID: 0345343893 Enrollment ID: O20070321000445 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
| Entity Name | Outer Banks Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891050357 PECOS PAC ID: 3173652096 Enrollment ID: O20100602000156 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
| Entity Name | Dlp Central Carolina Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184163883 PECOS PAC ID: 3577840420 Enrollment ID: O20170503000867 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William John Horan, MD 460 Burma Rd W, Marion, NC 28752-5278 Ph: (828) 318-3284 | William John Horan, MD 220 Nash Medical Arts Mall, Rocky Mount, NC 27804-1470 Ph: (252) 962-4550 |
News Archive
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.
For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.
In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, discuss an amendment that teaching hospitals in the U.S. hope will make it into final health care legislation. The amendement would add 15,000 residency slots to the 100,000 residencies supported by the federal government.
The drug galantamine (used for treatment of mild to moderate dementia) did not demonstrate a clinical benefit in treating chronic fatigue syndrome when compared with placebo, according to a study in the September 8 issue of JAMA.
› Verified 1 days ago
Walter Douglas Harrison, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 Nash Medical Arts Mall, Suite A, Rocky Mount, NC 27804 Phone: 252-937-0227 Fax: 252-937-3105 | |
Dr. Reece Alkire, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 220 Nash Medical Arts Mall, Rocky Mount, NC 27804 Phone: 252-962-4550 Fax: 252-962-4551 | |
Dr. Robert Mark Pate, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1041 Noell Ln, Suite 103, Rocky Mount, NC 27804 Phone: 252-937-8262 Fax: 252-937-8262 | |
Dr. Clarisse Sornsay Muenyi, MD, PHD Surgery Medicare: Medicare Enrolled Practice Location: 220 Nash Medical Arts Mall, Rocky Mount, NC 27804 Phone: 252-962-4550 Fax: 252-962-4551 | |
Stuart K Todd, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1508 Jeremy Ln, Rocky Mount, NC 27803 Phone: 252-443-4361 Fax: 252-443-0096 | |
Lisa C Nelson-robinson, MD Surgery Medicare: Medicare Enrolled Practice Location: 250 Nash Medical Arts Mall, Suite A, Rocky Mount, NC 27804 Phone: 252-937-0227 Fax: 252-937-3105 | |
Austin Lee Roach Mcjunkins, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 804 English Rd Ste 100, Rocky Mount, NC 27804 Phone: 252-443-3133 Fax: 252-443-6726 |